Amylin Goes A Little Wizard Of Oz On Shareholders - Seekingalpha.com

Although this may raise valid questions about the long-term profitability of the Byetta-to-Bydureon switch among the bear camp, compared to the M&A buzz it's like holding a match next to a stadium floodlight. Along similar lines, I wonder if the potential ...

Amylin Said to Attract Interest From Pfizer, AstraZeneca - Businessweek

First-round bids are due in the next two weeks, said two of the people. Amylin, the maker of the diabetes drugs Bydureon and Byetta, has a market capitalization of more than $4 billion and generated more than $650 million in revenue (AMLN) ...

Fda Patient Safety News March 2005 - Radio Egypt

The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters. We do not ...

Lilly, Jaguar Land Rover, Viacom: Intellectual Property - Bloomberg

The drugmaker is interested in buying San Diego-based Amylin Pharmaceuticals Inc. (AMLN) and its diabetes drugs Bydureon and Byetta, which generated more than $650 million in revenue last year, Bloomberg reported on May 15. Warner Chilcott Plc ...

Plavix's Loss Means Little Gain by Rival Blood Thinners - Bloomberg

The drugmaker is interested in buying San Diego-based Amylin Pharmaceuticals Inc. (AMLN) and its diabetes drugs Bydureon and Byetta, which generated more than $650 million in revenue last year, Bloomberg reported on May 15. To contact the ...

ABC 4 Investigates: The 'Skinny Shot' - ABC 4

Three shots for type 2 diabetics are on the market: Victoza, Byetta and Bydureon. The shots trick the mind into thinking the body is fuller faster. The prescriptions range from about $200 to $400 and if the patient stops taking the shot, the weight is ...

What Food Cravings and Gila Monsters Have in Common - eMaxHealth.com

Also known by the trade name Byetta, exenatide was approved by the Food and Drug Administration in April 2005 to help manage blood sugar levels in individuals who have type 2 diabetes. Now, at Sahlgrenska Academy, University of Gothenburg, investigators ...

Drugs that can make you gain weight - FOX News

Metformin, Byetta, and Januvia are more likely to cause weight loss, Dr. Aronne says. (Dr. Aronne receives research support from and consults for the companies that make Byetta and other drugs.) Insulin tends to promote weight gain. But certain ...

Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 - new market research report - Transworld News

The annual cost of type 2 diabetes therapy was driven by the uptake of newly approved drugs, such as Actos (pioglitazone) and Avandia (rosiglitazone) until 2006 and the launch of new therapies, such as Levemir (insulin detemir), Byetta (exenatide), Januvia ...

The huge potential of GLP-1 receptor agonists in the diabetes market opens opportunities for technology providers and pharma companies - msnbc.com

The study revealed that in addition to the three approved and marketed GLP-1R agonists (Byetta, Victoza and once-weekly Bydureon) 66 R&D projects including eight life cycle versions are in the pipeline over all R&D stages. The vast majority of ...